Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Douglas A. McIntyre | Aug 18, 2008 at 2:29 PM EDT

Eil Lilly (LLY) Death Drug Needs More Regulation

If there wasn’t enough already wrong with the FDA drug approval process, diabetes drug Byetta, created for patients by Elli…

Douglas A. McIntyre | Aug 13, 2008 at 5:49 AM EDT

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen…

Douglas A. McIntyre | Aug 7, 2008 at 7:17 AM EDT

Illumina Gets Secondary Behind It (ILMN)

Illumina Inc. (NASDAQ: ILMN) has priced its proposed secondary offering of 3.5 million shares at $87.50 per share. This will…

Douglas A. McIntyre | Aug 4, 2008 at 4:15 PM EDT

Alnylam Cancels Conference… What’s Brewing? (ALNY)

We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides…

Douglas A. McIntyre | Aug 4, 2008 at 8:21 AM EDT

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…

Douglas A. McIntyre | Aug 1, 2008 at 10:16 AM EDT

CardioNet Defies Prior Secondary Trends (BEAT)

CardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering. The company sold…

Douglas A. McIntyre | Aug 1, 2008 at 9:24 AM EDT

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We…

Douglas A. McIntyre | Jul 31, 2008 at 6:59 AM EDT

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a…

Douglas A. McIntyre | Jul 29, 2008 at 4:09 PM EDT

Align’s Guidance: Wearing a Retainer in Public (ALGN)

Align Technology Inc. (NASDAQ: ALGN) has just posted some mixed earnings. Regardless of Wall Street’s and Main Street’s love of…

Douglas A. McIntyre | Jul 28, 2008 at 3:23 PM EDT

Amgen Defying Earnings Concerns (AMGN)

Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis…

Douglas A. McIntyre | Jul 28, 2008 at 12:50 PM EDT

Amgen Earnings Now A Coin Toss? (AMGN)

After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s…

Douglas A. McIntyre | Jul 27, 2008 at 10:52 AM EDT

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

This weekend and this last week has created a lot of buzz around the mighty medical robotics player Intuitive Surgical…

Douglas A. McIntyre | Jul 25, 2008 at 8:21 AM EDT

IPO FILING: AutoGenomics Inc.

Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration…

Douglas A. McIntyre | Jul 24, 2008 at 7:02 AM EDT

GE Makes a Health Care Acquisition (GE, VITL)

Vital Signs Inc. (NASDAQ: VITL) is going to gap way up this morning. The company is being acquired by General…

Douglas A. McIntyre | Jul 23, 2008 at 2:17 PM EDT

Genentech & Roche Merger Coming Under More Fire (DNA)

Genentech Inc. (NYSE: DNA) is running into some issues over the merger with Roche at $89.00 per share. Wall Street…

1 … 348 349 350 351 352 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Eil Lilly (LLY) Death Drug Needs More Regulation

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Illumina Gets Secondary Behind It (ILMN)

Alnylam Cancels Conference… What’s Brewing? (ALNY)

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

CardioNet Defies Prior Secondary Trends (BEAT)

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Align’s Guidance: Wearing a Retainer in Public (ALGN)

Amgen Defying Earnings Concerns (AMGN)

Amgen Earnings Now A Coin Toss? (AMGN)

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

IPO FILING: AutoGenomics Inc.

GE Makes a Health Care Acquisition (GE, VITL)

Genentech & Roche Merger Coming Under More Fire (DNA)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Eil Lilly (LLY) Death Drug Needs More Regulation

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Illumina Gets Secondary Behind It (ILMN)

Alnylam Cancels Conference… What’s Brewing? (ALNY)

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

CardioNet Defies Prior Secondary Trends (BEAT)

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Align’s Guidance: Wearing a Retainer in Public (ALGN)

Amgen Defying Earnings Concerns (AMGN)

Amgen Earnings Now A Coin Toss? (AMGN)

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

IPO FILING: AutoGenomics Inc.

GE Makes a Health Care Acquisition (GE, VITL)

Genentech & Roche Merger Coming Under More Fire (DNA)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation